365 related articles for article (PubMed ID: 17364995)
1. Treatment of thrombotic microangiopathies with plasma exchange.
Basic-Jukic N; Kes P; Bubic-Filipi L; Brunetta B
Hematology; 2007 Feb; 12(1):63-7. PubMed ID: 17364995
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and management of thrombotic microangiopathies.
Ruggenenti P; Remuzzi G
J Nephrol; 1998; 11(6):300-10. PubMed ID: 10048496
[TBL] [Abstract][Full Text] [Related]
3. [Thrombotic microangiopathy in adults].
Barrientos GJ; Michelangelo H
Medicina (B Aires); 2006; 66(4):289-95. PubMed ID: 16977962
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of thrombotic microangiopathies].
Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
[TBL] [Abstract][Full Text] [Related]
5. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
Page EE; Little DJ; Vesely SK; George JN
Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
[TBL] [Abstract][Full Text] [Related]
6. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.
Yang CW; Chen YC; Dunn P; Chang MY; Fang JT; Huang CC
Ren Fail; 2003 Jan; 25(1):21-30. PubMed ID: 12617330
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
9. [Microangiopathic hemolytic anemias. Clinical pattern, therapy and clinical course in 14 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome].
Krause M; Fehr J; Gmür J; Keusch G; Frick P; Oelz O
Schweiz Med Wochenschr; 1986 Nov; 116(48):1666-74. PubMed ID: 3798063
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy syndrome as an AIDS-defining illness: the experience of J. Stroger Hospital of Cook County.
Tamkus D; Jajeh A; Osafo D; Hadad L; Bhanot B; Yogore MG
Clin Adv Hematol Oncol; 2006 Feb; 4(2):145-9. PubMed ID: 16728923
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.
Mulay S; Kreuter JD; Bryant SC; Elliott MA; Hogan WJ; Winters JL; Gastineau DA
J Clin Apher; 2015 Jun; 30(3):147-53. PubMed ID: 25230249
[TBL] [Abstract][Full Text] [Related]
12. ANCA negative pulmonary renal syndrome with pathologic findings of thrombotic microangiopathy.
Abdallah E; Al-Helal B; Al-Rashidi A; Asad R
Arab J Nephrol Transplant; 2013 Jan; 6(1):31-5. PubMed ID: 23282231
[TBL] [Abstract][Full Text] [Related]
13. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
15. [Thrombotic microangiopathy after kidney transplantation].
Basić-Jukić N; Jurić I; Brunetta-Gavranić B; Kes P; Bubić-Filipi L; Glavas-Boras S
Acta Med Croatica; 2008; 62 Suppl 1():93-6. PubMed ID: 18578340
[TBL] [Abstract][Full Text] [Related]
16. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM; Licht C; Muus P; Greenbaum LA; Babu S; Bedrosian C; Bingham C; Cohen DJ; Delmas Y; Douglas K; Eitner F; Feldkamp T; Fouque D; Furman RR; Gaber O; Herthelius M; Hourmant M; Karpman D; Lebranchu Y; Mariat C; Menne J; Moulin B; Nürnberger J; Ogawa M; Remuzzi G; Richard T; Sberro-Soussan R; Severino B; Sheerin NS; Trivelli A; Zimmerhackl LB; Goodship T; Loirat C
N Engl J Med; 2013 Jun; 368(23):2169-81. PubMed ID: 23738544
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic.
Thompson CE; Damon LE; Ries CA; Linker CA
Blood; 1992 Oct; 80(8):1890-5. PubMed ID: 1391952
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic microangiopathies: an update.
Franchini M
Hematology; 2006 Jun; 11(3):139-46. PubMed ID: 17325953
[TBL] [Abstract][Full Text] [Related]
19. Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases.
Dervenoulas J; Tsirigotis P; Bollas G; Pappa V; Xiros N; Economopoulos T; Pappa M; Mellou S; Kostourou A; Papageorgiou E; Raptis SA
Ann Hematol; 2000 Feb; 79(2):66-72. PubMed ID: 10741917
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
